Galderma's Restylane Contour Cleared for Temple Hollowing — New Indication, Familiar Filler

Temple volume loss is a recognized marker of age and a frequent patient complaint, yet it has remained underserved by cleared indications. Off-label use of volumizers has been standard practice, but a cleared indication removes prescriber liability and simplifies reimbursement conversations (where applicable). For practices, this means adding temple augmentation to your standard consultation checklist and training staff on patient selection and injection technique in a delicate zone near the temporal artery and superficial temporal nerve. Restylane Contour's approval here directly competes with Juvéderm's existing temple-use data and Revance's RHA Dynamic fillers, which also carry temple/midface indications. The real differentiation lies in your injection technique and patient outcomes—not the label alone.